Harnessing Genomics and Biotechnology to Improve Global Health Equity

5 October 2001

journal article
editorial
Published by American Association for the Advancement of Science (AAAS) in Science

Vol. 294 (5540) , 87-89
https://doi.org/10.1126/science.1062633

Abstract

With decisive and timely action, genome-related biotechnology can be harnessed to improve global health equity. In June 2002 in Kananaskis, Canada, leaders of the G8 industrial nations will develop an action plan to support implementation of the New African Initiative. By extending their discussion of health issues raised in the New African Initiative to include genomics, G8 leaders could signal their intention to increase global health equity by preventing a health genomics divide from developing. There are already some early and growing examples of genome-related biotechnology being applied successfully to health problems in developing countries. But how can genomics be systematically harnessed to benefit health in developing countries? We propose a five-point strategy, including research, capacity strengthening, consensus building, public engagement, and an investment fund.

Keywords

This publication has 9 references indexed in Scilit:

Frequency of C3435T polymorphism of MDR1 gene in African people
The Lancet, 2001
Genetics and developing countries
BMJ, 2001
Beyond Helsinki: a vision for global health ethics
BMJ, 2001
Introduction
Published by Springer Nature ,2001
Avoiding Frankendrugs
Nature Biotechnology, 2000
Published by Springer Nature ,2000
Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial Drugs
Science, 1999
A Low-Cost Approach To PCR
Published by Oxford University Press (OUP) ,1998
Appropriate transfer of molecuar technology to latin america for publica health and biomedical science
Biochemical Education, 1996